Heron Capital Stock from 2010 to 2024

HRTX Stock

USD 1.06 0.06 5.36%

Heron Therapeuti Capital Stock yearly trend continues to be fairly stable with very little volatility. Capital Stock will likely drop to about 1.2 M in 2024. Capital Stock is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. View All Fundamentals

Capital Stock

First Reported

2010-12-31

Previous Quarter

1.5 M

Current Value

1.2 M

Quarterly Volatility

215.6 K

Credit Downgrade

Yuan Drop

Covid

Check Heron Therapeuti financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heron Therapeuti's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3 M, Interest Expense of 4.1 M or Total Revenue of 133.4 M, as well as many indicators such as Price To Sales Ratio of 1.76, Dividend Yield of 0.0 or Days Sales Outstanding of 110. Heron financial statements analysis is a perfect complement when working with Heron Therapeuti Valuation or Volatility modules.

Check out the analysis of Heron Therapeuti Correlation against competitors.

For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.

Latest Heron Therapeuti's Capital Stock Growth Pattern

Below is the plot of the Capital Stock of Heron Therapeuti over the last few years. It is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. Heron Therapeuti's Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Heron Therapeuti's overall financial position and show how it may be relating to other accounts over time.

Capital Stock

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Capital Stock

Timeline

Heron Capital Stock Regression Statistics

	Arithmetic Mean	915,013
	Geometric Mean	895,351
	Coefficient Of Variation	23.57
	Mean Deviation	161,486
	Median	782,000
	Standard Deviation	215,631
	Sample Variance	46.5B
	Range	721K
	R-Value	0.78
	Mean Square Error	19.3B
	R-Squared	0.61
	Significance	0.0005
	Slope	37,801
	Total Sum of Squares	651B

Heron Capital Stock History

	2024	1.2 M
	2023	1.5 M
	2022	1.2 M
	2021	1 M
	2020	913 K
	2019	903 K

Other Fundumenentals of Heron Therapeuti

Issuance Of Capital Stock

Heron Therapeuti Capital Stock component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Accounts Payable	Common Stock	Short Term Investments	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Capital Surpluse	Short Long Term Debt	Long Term Debt Total	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.78	0.07	-0.65	0.78	0.5	1.0	0.41	0.35	-0.06	0.88	0.6	0.7	0.82	0.76	0.31	0.83	0.85	0.85	0.27
Total Stockholder Equity	0.78		-0.51	-0.04	0.29	-0.15	0.83	0.28	0.34	-0.19	0.87	-0.01	0.22	0.99	0.2	0.09	0.4	0.9	0.9	-0.31
Net Debt	0.07	-0.51		-0.7	0.51	0.81	0.0	-0.26	-0.2	0.27	-0.05	0.75	0.49	-0.44	0.61	-0.07	0.34	-0.16	-0.16	0.83
Retained Earnings	-0.65	-0.04	-0.7		-0.88	-0.97	-0.58	-0.29	-0.06	-0.15	-0.34	-0.98	-0.83	-0.12	-0.98	-0.34	-0.85	-0.24	-0.24	-0.84
Net Receivables	0.78	0.29	0.51	-0.88		0.83	0.75	0.44	0.39	0.13	0.55	0.83	0.89	0.38	0.92	0.49	0.91	0.45	0.46	0.66
Total Liab	0.5	-0.15	0.81	-0.97	0.83		0.43	0.25	0.08	0.17	0.2	0.96	0.8	-0.07	0.93	0.37	0.76	0.1	0.1	0.86
Total Current Assets	1.0	0.83	0.0	-0.58	0.75	0.43		0.42	0.4	-0.08	0.91	0.53	0.66	0.87	0.7	0.32	0.8	0.88	0.88	0.2
Short Term Debt	0.41	0.28	-0.26	-0.29	0.44	0.25	0.42		0.62	-0.14	0.13	0.15	0.48	0.29	0.32	0.95	0.58	0.1	0.1	0.04
Accounts Payable	0.35	0.34	-0.2	-0.06	0.39	0.08	0.4	0.62		-0.2	0.33	-0.08	0.3	0.34	0.1	0.66	0.36	0.26	0.27	-0.2
Common Stock	-0.06	-0.19	0.27	-0.15	0.13	0.17	-0.08	-0.14	-0.2		-0.11	0.19	0.22	-0.16	0.12	-0.06	0.07	-0.08	-0.07	0.27
Short Term Investments	0.88	0.87	-0.05	-0.34	0.55	0.2	0.91	0.13	0.33	-0.11		0.3	0.46	0.9	0.48	0.02	0.56	0.96	0.97	0.03
Property Plant Equipment	0.6	-0.01	0.75	-0.98	0.83	0.96	0.53	0.15	-0.08	0.19	0.3		0.79	0.07	0.96	0.22	0.78	0.24	0.24	0.85
Current Deferred Revenue	0.7	0.22	0.49	-0.83	0.89	0.8	0.66	0.48	0.3	0.22	0.46	0.79		0.29	0.86	0.52	0.87	0.41	0.41	0.61
Net Tangible Assets	0.82	0.99	-0.44	-0.12	0.38	-0.07	0.87	0.29	0.34	-0.16	0.9	0.07	0.29		0.28	0.11	0.46	0.92	0.92	-0.22
Capital Surpluse	0.76	0.2	0.61	-0.98	0.92	0.93	0.7	0.32	0.1	0.12	0.48	0.96	0.86	0.28		0.35	0.88	0.4	0.4	0.77
Short Long Term Debt	0.31	0.09	-0.07	-0.34	0.49	0.37	0.32	0.95	0.66	-0.06	0.02	0.22	0.52	0.11	0.35		0.57	-0.02	-0.02	0.16
Long Term Debt Total	0.83	0.4	0.34	-0.85	0.91	0.76	0.8	0.58	0.36	0.07	0.56	0.78	0.87	0.46	0.88	0.57		0.47	0.47	0.62
Net Invested Capital	0.85	0.9	-0.16	-0.24	0.45	0.1	0.88	0.1	0.26	-0.08	0.96	0.24	0.41	0.92	0.4	-0.02	0.47		1.0	-0.11
Net Working Capital	0.85	0.9	-0.16	-0.24	0.46	0.1	0.88	0.1	0.27	-0.07	0.97	0.24	0.41	0.92	0.4	-0.02	0.47	1.0		-0.1
Capital Stock	0.27	-0.31	0.83	-0.84	0.66	0.86	0.2	0.04	-0.2	0.27	0.03	0.85	0.61	-0.22	0.77	0.16	0.62	-0.11	-0.1

Click cells to compare fundamentals

About Heron Therapeuti Financial Statements

Heron Therapeuti investors use historical fundamental indicators, such as Heron Therapeuti's Capital Stock, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Heron Therapeuti. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Capital Stock	1.5 M	1.2 M
Issuance Of Capital Stock	29.7 M	28.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Heron Stock Analysis

When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Heron Capital Stock from 2010 to 2024

Latest Heron Therapeuti's Capital Stock Growth Pattern

Heron Capital Stock Regression Statistics

Heron Capital Stock History

Other Fundumenentals of Heron Therapeuti

Heron Therapeuti Capital Stock component correlations

About Heron Therapeuti Financial Statements

Also Currently Popular

Additional Tools for Heron Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY